UCLH, situated in the heart of London, is one of the largest NHS trusts in the United Kingdom and provides first-class acute and specialist services in six hospitals.
UCL Hospitals Charitable Foundation is the main fundraising charity for key research, building and equipment projects across all University College London Hospitals. Thanks to the support and generosity of our supporters we were able to raise over £28 million towards the UCH Macmillan Cancer Centre development. We are continuing to help UCLH NHS Foundation Trust deliver cutting edge research and first-class patient care by supporting a number of new projects across our hospitals. A list of our current fundraising projects can be found under the 'Projects' header at the top of this page.
We rely on the generosity of our supporters in order to help us to run projects that positively change people's lives both now and in the future. By choosing to donate to one of our projects, or take part in one of our events, you are directly improving the experience of our patients.
Thank you for your support.
We have three places in this iconic run through London's parks. With lockdown easing and the vaccination programme underway, many of us are starting to plan for the future. If you enjoy running and want something to train for, what better way to embrace a new challenge than to take part in this half marathon, raising money for our vital funds? The run takes place on Sunday 10th October 2021.
UCL Hospitals Charitable Foundation is honoured to be working closely with Professor Sam Janes and the Lungs for Living team, fundraising in support of the exciting and pioneering Summit Study. The Summit Study is one of the largest trials of its kind in the world.
Thanks to a generous three year grant from the Rosetrees Trust, Clinical Research Fellow Dr. Lukas Kalinke has been recruited to deliver the world's first ever Electrocautery Ablation for the pRevention of Lung cancer (EARL) Trial. This trial sets out to discover whether squamous cell lung cancer (SQCC) can be prevented with early treatment of pre-cancerous lesions.